4 hours ago
1
Grandbrothers/iStock Editorial via Getty Images
- Shares of Eton Pharmaceuticals (NASDAQ:ETON) added ~8% in the premarket on Tuesday after the FDA agreed to review its marketing application for ET-600, a potential treatment for a rare hormonal disorder known as central diabetes insipidus.
- Also known as arginine
English (US) ·